Variant report

Variant	esv1822175
Chromosome Location	chr6:35754933-35766151
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BHLHE40	chr6:35760699-35760763	K562	blood:	n/a	n/a
2	BHLHE40	chr6:35758607-35758807	HepG2	liver:	n/a	n/a
3	BHLHE40	chr6:35765017-35765289	K562	blood:	n/a	n/a
4	CEBPB	chr6:35758462-35758824	IMR90	lung:	n/a	n/a
5	CEBPB	chr6:35756271-35756457	HepG2	liver:	n/a	n/a
6	CEBPB	chr6:35758444-35758768	MCF-7	breast:	n/a	n/a
7	CEBPB	chr6:35762562-35762885	K562	blood:	n/a	n/a
8	CEBPB	chr6:35758455-35758789	K562	blood:	n/a	n/a
9	CEBPB	chr6:35758405-35758921	A549	lung:	n/a	n/a
10	CEBPB	chr6:35758448-35758812	H1-hESC	embryonic stem cell:	n/a	n/a
11	CEBPB	chr6:35758561-35758682	HepG2	liver:	n/a	n/a
12	CEBPB	chr6:35758454-35758819	A549	lung:	n/a	n/a
13	CEBPB	chr6:35758461-35758817	K562	blood:	n/a	n/a
14	CEBPB	chr6:35758463-35758813	HepG2	liver:	n/a	n/a
15	CEBPB	chr6:35758467-35758814	Hela-S3	cervix:	n/a	n/a
16	CTCF	chr6:35754820-35754970	GM12867	blood:	n/a	n/a
17	CTCF	chr6:35756160-35756310	GM12865	blood:	n/a	n/a
18	CTCF	chr6:35765740-35765890	GM12864	blood:	n/a	n/a
19	CTCF	chr6:35760640-35760790	GM12868	blood:	n/a	n/a
20	CTCF	chr6:35756680-35756830	GM12873	blood:	n/a	chr6:35756799-35756809
21	CTCF	chr6:35755520-35755670	GM12875	blood:	n/a	n/a
22	CTCF	chr6:35760300-35760450	AG04449	skin:	n/a	n/a
23	CTCF	chr6:35766010-35766063	H1-hESC	embryonic stem cell:	n/a	n/a
24	E2F4	chr6:35759420-35759424	MCF10A-Er-Src	breast:	n/a	n/a
25	E2F6	chr6:35761154-35761630	H1-hESC	embryonic stem cell:	n/a	chr6:35761248-35761260
26	E2F6	chr6:35761233-35761368	K562	blood:	n/a	chr6:35761248-35761260
27	E2F6	chr6:35761091-35761480	H1-hESC	embryonic stem cell:	n/a	chr6:35761248-35761260
28	EGR1	chr6:35763349-35763621	K562	blood:	n/a	chr6:35763477-35763491 chr6:35763478-35763491 chr6:35763479-35763490 chr6:35763479-35763490 chr6:35763479-35763488
29	EGR1	chr6:35765030-35765252	K562	blood:	n/a	n/a
30	ELF1	chr6:35764865-35765253	GM12878	blood:	n/a	n/a
31	FOXA1	chr6:35764086-35764407	T-47D	breast:	n/a	n/a
32	FOXA1	chr6:35764145-35764400	T-47D	breast:	n/a	n/a
33	GTF2F1	chr6:35765022-35765053	H1-hESC	embryonic stem cell:	n/a	n/a
34	GTF2F1	chr6:35763645-35763723	K562	blood:	n/a	n/a
35	HNF4A	chr6:35755377-35755745	HepG2	liver:	n/a	chr6:35755619-35755634 chr6:35755620-35755632 chr6:35755620-35755633 chr6:35755620-35755632 chr6:35755619-35755634 chr6:35755620-35755632 chr6:35755619-35755634 chr6:35755618-35755633 chr6:35755619-35755634
36	HNF4A	chr6:35755424-35755827	HepG2	liver:	n/a	chr6:35755619-35755634 chr6:35755620-35755632 chr6:35755620-35755633 chr6:35755620-35755632 chr6:35755619-35755634 chr6:35755620-35755632 chr6:35755619-35755634 chr6:35755618-35755633 chr6:35755619-35755634
37	JUN	chr6:35765331-35765335	H1-hESC	embryonic stem cell:	n/a	n/a
38	MAFF	chr6:35762574-35762875	K562	blood:	n/a	chr6:35762725-35762739 chr6:35762719-35762737
39	MAFF	chr6:35762658-35762770	HepG2	liver:	n/a	chr6:35762725-35762739 chr6:35762719-35762737
40	MAFF	chr6:35758034-35758157	K562	blood:	n/a	n/a
41	MAFF	chr6:35756435-35756454	HepG2	liver:	n/a	n/a
42	MAFK	chr6:35762633-35762864	Hela-S3	cervix:	n/a	chr6:35762726-35762736 chr6:35762726-35762735 chr6:35762722-35762742 chr6:35762721-35762736 chr6:35762725-35762739
43	MAFK	chr6:35756515-35756538	HepG2	liver:	n/a	n/a
44	MAFK	chr6:35762557-35762899	K562	blood:	n/a	chr6:35762726-35762736 chr6:35762726-35762735 chr6:35762722-35762742 chr6:35762721-35762736 chr6:35762725-35762739
45	MAFK	chr6:35762562-35762855	HepG2	liver:	n/a	chr6:35762726-35762736 chr6:35762726-35762735 chr6:35762722-35762742 chr6:35762721-35762736 chr6:35762725-35762739
46	MAFK	chr6:35762579-35762870	HepG2	liver:	n/a	chr6:35762726-35762736 chr6:35762726-35762735 chr6:35762722-35762742 chr6:35762721-35762736 chr6:35762725-35762739
47	MAFK	chr6:35758054-35758231	HepG2	liver:	n/a	n/a
48	MAX	chr6:35765943-35766141	K562	blood:	n/a	chr6:35766039-35766048 chr6:35766038-35766048 chr6:35766038-35766049 chr6:35766039-35766048 chr6:35766040-35766047
49	MAX	chr6:35765792-35766276	H1-hESC	embryonic stem cell:	n/a	chr6:35766039-35766048 chr6:35766038-35766048 chr6:35766038-35766049 chr6:35766039-35766048 chr6:35766040-35766047
50	MAX	chr6:35761136-35761546	H1-hESC	embryonic stem cell:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr6:35755609-35755659	SKMC	muscle:	n/a
2	chr6:35755609-35755659	SKMC	muscle:	n/a
3	chr6:35762844-35762894	HEK293	kidney:	embryo
4	chr6:35766021-35766071	ECC-1	luminal epithelium:	n/a
5	chr6:35764958-35765008	CMK	blood:	n/a
6	chr6:35765176-35765226	T-47D	breast:	n/a
7	chr6:35765176-35765226	LNCaP	prostate:	n/a
8	chr6:35765215-35765265	HIPEpiC	eye:	n/a
9	chr6:35766021-35766071	HAEpiC	amniotic membrane:	n/a
10	chr6:35765176-35765226	ProgFib	skin:	n/a
11	chr6:35756942-35756992	HMEC	breast:	n/a
12	chr6:35762844-35762894	Hela-S3	cervix:	n/a
13	chr6:35754906-35754956	MCF-7	breast:	n/a
14	chr6:35765215-35765265	NB4	blood:	n/a
15	chr6:35765176-35765226	MCF10A-Er-Src	breast:	n/a
16	chr6:35762844-35762894	Caco-2	colon:	n/a
17	chr6:35754906-35754956	HEEpiC	esophagus:	n/a
18	chr6:35765215-35765265	AG09319	gingival:	n/a
19	chr6:35765176-35765226	GM12891	blood:	n/a
20	chr6:35762844-35762894	HUVEC	blood vessel:	n/a
21	chr6:35765093-35765143	GM12878	blood:	n/a
22	chr6:35755609-35755659	MCF10A-Er-Src	breast:	n/a
23	chr6:35765146-35765196	T-47D	breast:	n/a
24	chr6:35765146-35765196	HEK293	kidney:	embryo
25	chr6:35765176-35765226	AG09309	skin:	n/a
26	chr6:35765215-35765265	Hepatocyte	liver:	n/a
27	chr6:35765589-35765639	RPTEC	kidney:	n/a
28	chr6:35754906-35754956	HepG2	liver:	n/a
29	chr6:35756942-35756992	BE2_C	brain:	n/a
30	chr6:35762844-35762894	SAEC	small airway:	n/a
31	chr6:35756942-35756992	SK-N-MC	brain:	n/a
32	chr6:35766051-35766101	U87	brain:	n/a
33	chr6:35755609-35755659	HCM	heart:	n/a
34	chr6:35765176-35765226	IMR90	lung:	fetal
35	chr6:35756942-35756992	ECC-1	luminal epithelium:	n/a
36	chr6:35765215-35765265	GM12891	blood:	n/a
37	chr6:35754906-35754956	HCT-116	colon:	n/a
38	chr6:35765589-35765639	BE2_C	brain:	n/a
39	chr6:35764958-35765008	HCT-116	colon:	n/a
40	chr6:35756942-35756992	HL-60	blood:	n/a
41	chr6:35755609-35755659	GM12891	blood:	n/a
42	chr6:35766021-35766071	AG04450	lung:	fetal
43	chr6:35765146-35765196	HEEpiC	esophagus:	n/a
44	chr6:35762844-35762894	ECC-1	luminal epithelium:	n/a
45	chr6:35766021-35766071	BE2_C	brain:	n/a
46	chr6:35765215-35765265	ProgFib	skin:	n/a
47	chr6:35766021-35766071	HepG2	liver:	n/a
48	chr6:35766051-35766101	LNCaP	prostate:	n/a
49	chr6:35755609-35755659	HRPEpiC	eye:	n/a
50	chr6:35766051-35766101	HCPEpiC	choroid plexus:	n/a

No.	Distal block	Cell Line	Cell type
1	chr6:35762091..35764853-chr6:35765476..35768100,2	MCF-7	breast:
2	chr6:35747942..35750162-chr6:35760132..35762411,2	MCF-7	breast:
3	chr6:35753638..35758618-chr6:35762629..35767095,7	K562	blood:
4	chr6:35760015..35761880-chr6:35763280..35765561,2	K562	blood:
5	chr6:35753847..35759789-chr6:35762486..35768711,9	K562	blood:
6	chr6:35742984..35745597-chr6:35763979..35765844,2	MCF-7	breast:
7	chr6:35753638..35758618-chr6:35762629..35767095,7	K562	blood:
8	chr6:35762283..35764266-chr6:35764644..35767426,2	MCF-7	breast:
9	chr6:35744273..35746880-chr6:35754146..35757378,3	K562	blood:
10	chr6:35760846..35763760-chr6:36163836..36166432,2	K562	blood:
11	chr6:35435012..35436668-chr6:35752247..35755003,2	MCF-7	breast:
12	chr6:35753847..35759789-chr6:35762486..35768711,9	K562	blood:
13	chr6:35762091..35764853-chr6:35765476..35768100,2	MCF-7	breast:
14	chr6:35762307..35765078-chr6:35772426..35774241,2	MCF-7	breast:

Variant related genes	Relation type
CLPS	TF binding region
CLPS	CpG island
ENSG00000096070	chromatin interactions
ENSG00000198755	chromatin interactions
ENSG00000137392	chromatin interactions
ENSG00000197753	chromatin interactions
ENSG00000196748	chromatin interactions
ENSG00000246982	chromatin interactions
ENSG00000204140	chromatin interactions

Extended variants
information (count: 644 )
Associated
traits (count: 108 )

Variant overlapped rSNPs/rCNVs (count:644 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs199711177	chr6:35754939-35754940	Bivalent/Poised TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
2	rs567215656	chr6:35754964-35754965	Bivalent/Poised TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
3	rs536070448	chr6:35754995-35754996	Bivalent/Poised TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
4	rs149236311	chr6:35755024-35755025	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs182052295	chr6:35755038-35755039	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs569463836	chr6:35755092-35755093	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs370406730	chr6:35755104-35755105	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs370948489	chr6:35755106-35755107	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs558467743	chr6:35755114-35755115	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs186388963	chr6:35755122-35755123	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs540225565	chr6:35755133-35755134	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs555849750	chr6:35755134-35755135	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs574000870	chr6:35755146-35755147	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs113492347	chr6:35755224-35755225	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs544009854	chr6:35755230-35755231	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs562384818	chr6:35755244-35755245	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs376158264	chr6:35755268-35755269	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs532959298	chr6:35755269-35755270	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs372610782	chr6:35755348-35755349	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs544932871	chr6:35755365-35755366	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs560175407	chr6:35755376-35755377	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs111960951	chr6:35755389-35755390	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs548674437	chr6:35755428-35755429	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs567358704	chr6:35755484-35755485	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs531394696	chr6:35755489-35755490	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs549898138	chr6:35755523-35755524	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs6927363	chr6:35755547-35755548	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
28	rs540022227	chr6:35755552-35755553	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs558440227	chr6:35755579-35755580	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs369132151	chr6:35755609-35755610	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs373408423	chr6:35755610-35755611	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs567022968	chr6:35755617-35755618	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs57267367	chr6:35755618-35755619	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
34	rs534200139	chr6:35755619-35755620	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs371334705	chr6:35755633-35755634	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs373782315	chr6:35755649-35755650	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs12211728	chr6:35755658-35755659	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs371335450	chr6:35755660-35755661	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs200011151	chr6:35755674-35755675	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs201083630	chr6:35755680-35755681	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs141726973	chr6:35755682-35755683	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs561535280	chr6:35755688-35755689	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs373793944	chr6:35755727-35755728	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs201001742	chr6:35755728-35755729	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs367548710	chr6:35755738-35755739	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs372322460	chr6:35755741-35755742	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs529542464	chr6:35755753-35755754	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs376822960	chr6:35755756-35755757	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs201485408	chr6:35755764-35755765	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs372544403	chr6:35755767-35755768	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:108)

Disease	PMID	Source
Follicular lymphoma	20505157	CNVD
Glioblastoma multiforme	21080181	CNVD
Ewing''s sarcoma	21437220	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Leukemia	21518781	CNVD
Cancer	21637783	CNVD
Facial dysmorphism	22105932	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Endometrial cancer	22040021	CNVD
Acute myeloid leukemia	16864856	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Bladder cancer	19088036	CNVD
Wilms tumour	21544195	CNVD
Uveal melanoma	21693616	CNVD
Biliary cancer	19435499	CNVD
Malaria	21533027	CNVD
Retinoblastoma	19183342	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21858162	CNVD
Ewing''s sarcoma	17952124	CNVD
Autism	21448237	CNVD
Melanoma	18172304	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Hepatocellular carcinoma	16750200	CNVD
Autism	22495311	CNVD
Cancer	16790693	CNVD
Cervical cancer	21062161	CNVD
Esophageal adenocarcinoma	18820669	CNVD
Systemic lupus erythematosus	17503323	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Urothelial carcinoma	18382360	CNVD
Cancer	21183584	CNVD
Hodgkin''s lymphoma	17606441	CNVD
small cell lung cancer	20016488	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Gastric cancer	17908304	CNVD
Metanephric adenoma	20802469	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Schizophrenia	19571808	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Neuroblastoma	16790693	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Breast cancer	16397240	CNVD
Retinoblastoma	22278416	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Systemic lupus erythematosus	20877625	CNVD
Cleidocranial dysplasia	18696259	CNVD
Holoprosencephaly	21359414	CNVD
Liposarcoma	21253554	CNVD
Uveal melanoma	20484589	CNVD
Fibroblasts	20926602	CNVD
Systemic lupus erythematosus	19279649	CNVD
Retinoblastoma	16790693	CNVD
Acute myocardial infarction	18032375	CNVD
Renal cell carcinoma	19150565	CNVD
Systemic lupus erythematosus	19591781	CNVD
Attention deficit hyperactivity disorder	19287146	CNVD
Autism	19287146	CNVD
Erythema nodosum in leprosy	19287146	CNVD
Henoch-schoenlein purpura	19287146	CNVD
Liver cirrhosis	19287146	CNVD
Systemic lupus erythematosus	19287146	CNVD
Autoimmune disease	19135723	CNVD
Congenital adrenal hyperplasia	18478071	CNVD
Systemic lupus erythematosus	19287147	CNVD
Osteosarcoma	16790693	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Cancer	22183965	CNVD
Melanoma	22183965	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Lung cancer	18438408	CNVD
Glioblastoma multiforme	21138945	CNVD
Breast cancer	21364760	CNVD
Basal cell lymphoma	19029149	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Myelofibrosis	22110671	CNVD
Liver carcinoma	19366792	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
Lung cancer	19153074	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Cancer	20164919	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD

Chromatin state (count:95 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:35746400-35755400	Weak transcription	Pancreas	Pancrea
2	chr6:35754200-35755400	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
3	chr6:35754400-35755000	Bivalent Enhancer	Cortex derived primary cultured neurospheres	brain
4	chr6:35754400-35755000	Bivalent Enhancer	Right Ventricle	heart
5	chr6:35754400-35755000	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle
6	chr6:35754400-35755200	Enhancers	iPS-15b Cell Line	embryonic stem cell
7	chr6:35754400-35756000	Bivalent Enhancer	Placenta	Placenta
8	chr6:35754600-35755000	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
9	chr6:35754600-35755000	Bivalent/Poised TSS	ES-WA7 Cell Line	embryonic stem cell
10	chr6:35754600-35755000	Bivalent/Poised TSS	Ganglion Eminence derived primary cultured neurospheres	brain
11	chr6:35754600-35755000	Flanking Bivalent TSS/Enh	Foreskin Fibroblast Primary Cells skin01	Skin
12	chr6:35754600-35755000	Flanking Bivalent TSS/Enh	Foreskin Fibroblast Primary Cells skin02	Skin
13	chr6:35754600-35755000	Flanking Bivalent TSS/Enh	Foreskin Keratinocyte Primary Cells skin03	Skin
14	chr6:35754600-35755000	Flanking Bivalent TSS/Enh	Foreskin Melanocyte Primary Cells skin01	Skin
15	chr6:35754600-35755000	Bivalent/Poised TSS	Colonic Mucosa	Colon
16	chr6:35754600-35755000	Flanking Bivalent TSS/Enh	Duodenum Mucosa	Duodenum
17	chr6:35754600-35755000	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
18	chr6:35754600-35755000	Bivalent Enhancer	Fetal Muscle Trunk	muscle
19	chr6:35754600-35755000	Bivalent Enhancer	Left Ventricle	heart
20	chr6:35754600-35755000	Bivalent Enhancer	Ovary	ovary
21	chr6:35754600-35755200	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
22	chr6:35754600-35755200	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
23	chr6:35754600-35755200	Flanking Bivalent TSS/Enh	Foreskin Keratinocyte Primary Cells skin02	Skin
24	chr6:35754600-35755200	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin03	Skin
25	chr6:35754600-35755400	Bivalent Enhancer	Breast Myoepithelial Primary Cells	Breast
26	chr6:35754600-35755600	Bivalent Enhancer	Liver	Liver
27	chr6:35754800-35755000	Bivalent Enhancer	Primary T helper cells fromperipheralblood	blood
28	chr6:35754800-35755000	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
29	chr6:35754800-35755000	Bivalent Enhancer	Esophagus	oesophagus
30	chr6:35754800-35755000	Bivalent Enhancer	Fetal Muscle Leg	muscle
31	chr6:35754800-35755000	Flanking Bivalent TSS/Enh	HMEC	breast
32	chr6:35754800-35755200	Bivalent Enhancer	Lung	lung
33	chr6:35754800-35755600	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
34	chr6:35754800-35755600	Bivalent Enhancer	HUES6 Cell Line	embryonic stem cell
35	chr6:35755000-35755200	Bivalent Enhancer	ES-I3 Cell Line	embryonic stem cell
36	chr6:35755000-35755200	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
37	chr6:35755000-35755200	Bivalent/Poised TSS	Duodenum Mucosa	Duodenum
38	chr6:35755000-35755200	Bivalent Enhancer	A549	lung
39	chr6:35755000-35755200	Bivalent Enhancer	HMEC	breast
40	chr6:35755000-35755400	Bivalent Enhancer	HepG2	liver
41	chr6:35755000-35755600	Bivalent Enhancer	ES-WA7 Cell Line	embryonic stem cell
42	chr6:35755000-35755600	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
43	chr6:35755000-35756000	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin01	Skin
44	chr6:35755200-35755400	Flanking Bivalent TSS/Enh	ES-I3 Cell Line	embryonic stem cell
45	chr6:35755200-35755400	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
46	chr6:35755200-35755400	Bivalent Enhancer	Duodenum Mucosa	Duodenum
47	chr6:35755200-35756600	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
48	chr6:35755400-35755800	Flanking Active TSS	HepG2	liver
49	chr6:35755400-35757000	Enhancers	Pancreas	Pancrea
50	chr6:35755400-35765600	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links